Skip to Content

OPTIVOL

OptiVol® Care Pathway

Patient Information

Medtronic, Inc. is sponsoring the OptiVol® Care Pathway Study, a prospective, randomized, multi-center, post-market clinical trial in the United States. The purpose of this clinical trial is to compare monthly versus quarterly review of Cardiac Compass® Trends with OptiVol for initiation of clinical action. It is hypothesized that monthly review of Cardiac Compass Trends with OptiVol will shorten time to clinical action as compared to quarterly review.

More details at: http://www.clinicaltrials.gov/ct2/show/NCT00847288

Study Number
NCT00847288

Clinical Trial Categories

  • Electrophysiology Trials

Also in this Section